Cholinergic modulation of mesolimbic dopamine function and reward

Physiology and Behavior

Volumn 104, Issue 1, 2011, Pages 76-81

  Mark, Gregory P ^a   Shabani, Shkelzen ^a   Dobbs, Lauren K ^a   Hansen, Stephen T ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Addiction; Cocaine; Dopamine; Feeding; Motivation

Indexed keywords

ACETYLCHOLINE; COCAINE; DOPAMINE; FUMARIC ACID; MECAMYLAMINE; MUSCARINIC M2 RECEPTOR AGONIST; NICOTINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE;

ARTICLE; BINGE EATING DISORDER; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; COCAINE DEPENDENCE; COMPULSION; DOPAMINERGIC NERVE CELL; DRUG SEEKING BEHAVIOR; FEEDING; HEALTH HAZARD; HUMAN; INTERNEURON; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTIVATION; NEUROBIOLOGY; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ACETYLCHOLINE; ANIMALS; COCAINE; DOPAMINE; FEEDING BEHAVIOR; MOTIVATION; NEURONS; NUCLEUS ACCUMBENS; REWARD; SELF ADMINISTRATION; SUBSTANTIA NIGRA; SYNAPSES; VENTRAL TEGMENTAL AREA;

EID: 79957648856     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.04.052     Document Type: Article

References (70)

1. Mogenson G.J., Jones D.L., Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Progress in Neurobiology 1980, 14:69-97.
2. Fibiger H.C., Phillips A.G. Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine system. Handbook of Physiology, Section 1: The Nervous System 1986, 647-675.
3. Koob G.F., Goeders N.E. Neuroanatomical substrates of drug self-administration. The neuropharmacological basis of reward 1989, 214-263. Oxford University Press, Oxford. J.M. Liebman, S.J. Cooper (Eds.).
4. Wise R.A. Opiate reward: sites and substrates. Neurosci Biobehav Rev 1989, 13:129-133.
5. Hernandez L., Hoebel B.G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Science 1988, 42:705-712.
6. Avena N.M., Rada P., Moise N., Hoebel B.G. Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neuroscience 2006, 139:813-820.
7. Mark G., Rada P., Pothos E., Hoebel B.G. Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum and hippocampus of freely-behaving rats. J Neurochem 1992, 58:2269-2274.
8. Avena N.M., Rada P., Hoebel B.G. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 2008, 32:20-39.
9. Rada P., Avena N.M., Hoebel B.G. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 2005, 134:737-744.
10. Rada P.V., Mark G.P., Hoebel B.G. Dopamine release in the nucleus accumbens by hypothalamic stimulation-escape behavior. Brain Res 1998, 782:228-234.
11. Hoebel B.G., Avena N.M., Rada P. Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol 2007, 7:617-627.
12. See R.E., McLaughlin J., Fuchs R.A. Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats. Neuroscience 2003, 117:477-483.
13. Vorel S.R., Liu X., Hayes R.J., Spector J.A., Gardner E.L. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 2001, 292:1175-1178.
14. Smith A.D., Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 1990, 13:259-265.
15. Meredith G.E., Chang H.T. Synaptic relationships of enkephalinergic and cholinergic neurons in the nucleus accumbens of the rat. Brain Res 1994, 667:67-76.
16. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci 1995, 12:527-535.
17. Di Chiara G., Morelli M., Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 1994, 17:228-233.
18. de Rover M., Lodder J.C., Kits K.S., Schoffelmeer A.N., Brussaard A.B. Cholinergic modulation of nucleus accumbens medium spiny neurons. Eur J Neurosci 2002, 16:2279-2290.
19. Woolf N.J., Butcher L.L. Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum. Brain Res Bull 1989, 23:519-540.
20. Oakman S.A., Faris P.L., Kerr P.E., Cozzari C., Hartman B.K. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 1995, 15:5859-5869.
21. Yeomans J.S. Role of tegmental cholinergic neurons in dopamine activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology 1995, 12:3-16.
22. Yeomans J., Baptista M. Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 1997, 57:915-921.
23. Picciotto M.R., Corrigall W.A. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci 2002, 22:3338-3341.
24. Maskos U., Molles B.E., Pons S., et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 2005, 436:103-107.
25. Alderson H.L., Latimer M.P., Winn P. Intravenous self-administration of nicotine is altered by lesions of the posterior, but not anterior, pedunculopontine tegmental nucleus. Eur J Neurosci 2006, 23:2169-2175.
26. Zanetti L., Picciotto M.R., Zoli M. Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice. Psychopharmacology (Berl) 2007, 190:189-199.
27. Mansvelder H.D., McGehee D.S. Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 2002, 53:606-617.
28. Soderpalm B., Ericson M., Olausson P., Blomqvist O., Engel J.A. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 2000, 113:85-96.
29. Le A.D., Wang A., Harding S., Juzytsch W., Shaham Y. Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats. Psychopharmacology 2003, 168:216-221.
30. Zachariou V., Caldarone B.J., Weathers-Lowin A., et al. Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology 2001, 24:576-589.
31. Bechtholt A.J., Mark G.P. Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats. Psychopharmacology (Berl) 2002, 162:178-185.
32. Shannon H.E., Peters S.C. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice. J Pharmacol Exp Ther 1990, 255:549-553.
33. Ichikawa J., Chung Y.C., Li Z., Dai J., Meltzer H.Y. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 2002, 958:176-184.
34. Bymaster F.P., Heath I., Hendrix J.C., Shannon H.E. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Ther 1993, 267:16-24.
35. Hagan J.J., Tonnaer J.A.D.M., Rijk H., Broekkamp C.L.E., van Delft A.M.L. Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity. Brain Res 1987, 410:69-73.
36. Rasmussen T., Sauerberg P., Nielsen E.B., et al. Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice. Eur J Pharmacol 2000, 402:241-246.
37. Ranaldi R., Woolverton W.L. Self-administration of cocaine: scopolamine combinations by rhesus monkeys. Psychopharmacology 2002, 161:442-448.
38. Fink-Jensen A., Fedorova I., Wortwein G., et al. Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res 2003, 74:91-96.
39. Crespo J.A., Sturm K., Saria A., Zernig G. Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J Neurosci 2006, 26:6004-6010.
40. Berlanga M.L., Olsen C.M., Chen V., et al. Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience 2003, 120:1149-1156.
41. Mark G.P., Hajnal A., Kinney A.E., Keys A.S. Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology 1999, 143:47-53.
42. Hikida T., Kaneko S., Isobe T., et al. Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens. Proc Nat Acad Sci 2001, 98:13351-13354.
43. Hikida T., Kitabatake Y., Pastan I., Nakanishi S. Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A 2003, 100:6169-6173.
44. Radhakishun F.S., van Ree J.M., Westerink B.H.C. Scheduled eating increases dopamine release in the nucleus accumbens of food-deprived rats as assessed with on-line brain dialysis. Neuroscience Letters 1988, 85:351-356.
45. Mark G.P., Blander D.S., Hoebel B.G. A conditioned stimulus decreases extracellular dopamine in the nucleus accumbens after the development of a learned taste aversion. Brain Research 1991, 551:308-310.
46. Sclafani A., Nissenbaum J.W. Robust conditioned flavor preferences produced by intragastric starch infusions in rats. Am J Physiol 1988, 255:R672-R675.
47. Mark G.P., Smith S.E., Rada P.V., Hoebel B.G. An appetitively conditioned taste elicits a preferential increase in mesolimbic dopamine release. Pharmacol Biochem Behav 1994, 48:651-660.
48. Butcher L.L. Nature and mechanisms of cholinergic-monoaminergic interactions in the brain. Life Sci 1977, 21:1207-1226.
49. De Souza H., Palmero-Neto J. A quantitative study of cholinergic-dopaminergic interactions in the central nervous system. Pharmacology 1982, 24:222-229.
50. Kasper K.L. The anticholinergic biperiden in depressive disorders. Pharmacopsychiatry 1981, 14:195-198.
51. Martin-Iverson M.T., Leclere J.-F., Fibiger H.C. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants. Eur J Pharmacol 1983, 94:193-201.
52. Butcher S.G., Butcher L.L. Origin and modulation of acetylcholine activity in the neostriatum. Brain Res 1974, 71:167-171.
53. Hoover D.B., Muth E.A., Jacobowitz D.M. A mapping of the distribution of acetylcholine, choline acetyltransferase and acetylcholinesterase in discrete areas of rat brain. Brain Res 1978, 153:295-306.
54. Lehmann J., Langer S.Z. The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?. Neuroscience 1983, 10:1105-1120.
55. Damsma G., De Boer P., Westerink B.H.C., Fibiger H.C. Dopaminergic regulation of striatal cholinergic interneurons. Naunyn-Schmiedeberg's Arch Pharmacol 1990, 342:523-527.
56. De Boer P., Damsma G., Schram Q., Stoof J.C., Zaagsma J., Westerink B.H.C. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn-Schmiedeberg's Arch Pharmacol 1992, 345:144-152.
57. Stadler H., Lloyd K.G., Gadea-Ciria M., Bartholini G. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res 1973, 55:476-480.
58. Stoof J.C., De Boer T., Sminia P., Mulder A.H. Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin. Eur J Pharmacol 1982, 84:211-214.
59. Tedford C.E., Crosby G., Iorio L.C., Chipkin R.E. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices. Eur J Pharmacol 1992, 211:169-176.
60. Mark G.P., Rada P.V., Weinberg J.B., Hoebel B.G. Extracellular acetylcholine is increased in the nucleus accumbens following the presentation of an aversively conditioned taste stimulus. Brain Res 1995, 688:184-188.
61. Rada P.V., Mark G.P., Yeomans J.J., Hoebel B.G. Acetylcholine release in ventral tegmental area by hypothalamic self-stimulation, eating, and drinking. Pharmacol Biochem Behav 2000, 65:375-379.
62. Dobbs L.K., Mark G.P. Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse. Neuroscience 2008, 156:700-711.
63. Shabani S., Foster R., Gubner N., Phillips T.J., Mark G.P. Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in rats. Neuroscience 2010, 170:559-569.
64. Ahmed S.H., Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 1998, 282:298-300.
65. Ahmed S.H., Koob G.F. Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology 1999, 146:303-312.
66. Zernig G., Ahmed S.H., Cardinal R.N., et al. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 2007, 80:65-119.
67. O'Brien C.P. Research advances in the understanding and treatment of addiction. Am J Addict 2003, 12(Suppl 2):S36-S47.
68. Schaffer H.J., Eber G.B. Temporal progression of cocaine dependence symptoms in the US National Comorbidity Survey. Addiction 2002, 97:543-554.
69. Hansen S.T., Mark G.P. The nicotinic acetylcholine receptor antagonist mecamylamine prevents escalation of cocaine self-administration in rats with extended daily access. Psychopharmacology (Berl) 2007, 194:53-61.
70. Reid M.S., Mickalian J.D., Delucchi K.L., Berger S.P. A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology 1999, 20:297-307.